Novartis Wins Judgment In Mylan Heart Drug Patent Fight

By Adam Lidgett · July 7, 2023, 1:45 PM EDT

A West Virginia federal judge said Mylan's proposed generic version of heart medication Entresto would infringe a pair of patents that Swiss pharmaceutical giant Novartis has on the brand-name product....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al

Case Number

1:19-cv-00201

Court

West Virginia Northern

Nature of Suit

835 Patent - Abbreviated New Drug Applications (ANDA)

Date Filed

October 30, 2019